In addition to presenting Sylvester Comprehensive Cancer Center research findings, Sylvester experts are available at ASCO to share perspectives on a wide variety of topics and studies ranging from breast cancer to sarcoma, prostate cancer, mesothelioma, melanoma, CNS tumors and more.
Below are summaries of recent Fred Hutchinson Cancer Center research findings and other news. If you’re covering the American Society for Clinical Oncology’s annual meeting, June 2-6 in Chicago, Illinois, see our list of Fred Hutch research highlights at ASCO and contact [email protected] to set up interviews with experts.
A drug combination that shows little overall survival benefit in white men with advanced prostate cancer has a far greater effect in Black men with the disease, according to interim results from a study led by the Duke Cancer Institute.
Children’s Hospital Los Angeles study assessed which anatomic features affect the clinical course for babies born with complete atrioventricular canal (CAVC) defects.
New research from Cleveland Clinic supports the theory that environmental exposures – such as red meat consumption and sugar intake – may play a role in the rising incidence of young-onset colorectal cancer. Researchers found that people younger than age 50 with colorectal cancer had lower levels of citrate, which is created in the process of converting food into energy, compared to older people diagnosed with colorectal cancer.
In response to the opioid epidemic in the United States, interventions to prevent over-prescribing and misuse of opioids were enacted at institutional, state, and federal levels. To assess how changes in the prescribing landscape affected patients, a research team from the Yale COPPER Center examined the rates of both new and persistent opioid prescribing in patients with cancer as well as in patients without cancer, utilizing data from SEER-Medicare.
Dr. Gilberto Lopes will present information on the Access to Oncology Medicines (ATOM) Coalition, a global initiative established by the Union for International Cancer Control and partners to reduce suffering and deaths from cancer in low- and lower middle-income countries by improving patient access to essential cancer medicine. The coalition includes academic medical, pharmaceutical companies, foundations and professional associations such as the American Society for Clinical Oncology (ASCO) and American Society for Clinical Pathology (ASCP).
Established in 1995, the Glaucoma Foundation's Annual Think Tank has significantly increased the number of people around the world working in the field of glaucoma. All of the speakers at this 2-day will attend in person and the conference will be live-streamed on Zoom.
Cedars-Sinai Cancer physician-scientists with expertise in liver, skin, lung, breast, colorectal, pancreatic, brain, prostate and endometrial cancers will be attending the American Society of Clinical Oncology annual meeting June 2-6 in Chicago and are available for in-person or virtual interviews to discuss the latest news and research.
Researchers will delve into the latest research in diabetes, obesity, reproductive health and other aspects of endocrinology during the Endocrine Society’s ENDO 2023 news conferences June 15-18.
Several phase 3 studies conducted by researchers from Dana-Farber Cancer Institute show promising results for patients with rectal, brain, and kidney cancers. The results of these studies, along with dozens of others led by Dana-Farber researchers, will be presented at the 2023 Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago.
A clinical trial, led by Dana-Farber Cancer Institute, has shown that a telephone-based weight loss program can help patients with breast cancer whose body mass index is in the overweight or obese range lower their weight by a meaningful degree.
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back. This special edition features presentations by MD Anderson researchers at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting.
Researchers from the Abramson Cancer Center and Perelman School of Medicine at the University of Pennsylvania will present data on the latest advances in clinical cancer research at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting from June 2-6 in Chicago, Illinois.
Breast cancer treatments that can save a woman’s life can seriously harm her sexual health. Although doctors have not historically been prepared to help patients manage these toxic side effects, Dr. Kristin Rojas at Sylvester Comprehensive Cancer Center has created a program to address women’s sexual health after cancer treatment.
Treatment with luspatercept improved red blood cell counts and erythroid responses compared to treatment with epoetin alfa in patients with myelodysplastic syndromes (MDS), allowing the majority to no longer require regular blood transfusions. Results from the Phase III COMMANDS trial, led by researchers at The University of Texas MD Anderson Cancer Center, were reported at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting.
Scientists from the American Cancer Society are presenting research studies at the 2023 Annual Meeting of the American Society of Clinical Oncology (ASCO) June 2-6 in Chicago, Illinois.
Hundreds of attendees joined the 2nd Transatlantic Exchange program on Friday, 5 May 2023, in Paris, France. The day-long session focused on artificial intelligence (AI) and data science in oncology.
Experts also available for interviews on trending topics and studies
Chronic obstructive pulmonary disease patients newly prescribed non-benzodiazepine benzodiazepine receptor agonists (NBZRAs) such as zolpidem (Ambien, Intermezzo and other brands), a class of hypnotic drugs prescribed for insomnia, did not have an increased risk of exacerbations requiring hospitalizations or of death than those prescribed other types of hypnotics, according to research published at the ATS 2023 International Conference.
Obstructive sleep apnea (OSA) tests may underestimate the severity of OSA in Black patients, according to research published at the ATS 2023 International Conference.
Fever was found to be the most common non-respiratory feature of infection with SARS-CoV-2, the virus that causes COVID-19, according to research published at the ATS 2023 International Conference.
In a randomized controlled trial, ICUconnect helped ICU physicians to reduce unmet palliative care needs of critically ill patients and their families better than standard care did, according to research published at the ATS 2023 International Conference.
For children with asthma residing in urban areas, the neighborhood they live in is a stronger predictor of whether they will have exacerbations (asthma attacks) than their family’s income or their parents’ level of educational attainment, according to research published at the ATS 2023 International Conference.
A new device invented with the help of an electrophysiologist at The Ohio State University Wexner Medical Center makes a heart procedure safer for patients suffering from atrial fibrillation (AFib), a common irregular heart rhythm.
Physicians and scientists from the UCLA Jonsson Comprehensive Cancer Center will discuss the latest research and clinical trial results on combination therapies for breast cancer, a potential new treatment for patients with recurrent glioma, and advances in PSMA PET guided radiotherapy for patients with prostate cancer, among other topics, at the American Society of Clinical Oncology’s annual meeting.
First Mount Sinai cardiologist to hold this prestigious position
Results from a new clinical trial found overweight and obese patients with persistent and paroxysmal atrial fibrillation (AF) who lose weight prior to a catheter ablation procedure have improved clinical outcomes.
Mount Sinai doctors and students will share new insights on prenatal care
Yale Cancer Center and Smilow Cancer Hospital scientists and clinicians will present new research at the 2023 Annual Meeting of the American Society of Clinical Oncology (ASCO), June 2nd to June 6th at McCormick Place in Chicago, Illinois. This year’s scientific program will feature more than 2,900 abstracts, covering all major diseases and research areas, including breast, lung, head and neck, gynecological, prostate, and gastric cancers.
Registration opens today for the American Society for Radiation Oncology's (ASTRO) 65th Annual Meeting, which will be held at the San Diego Convention Center, October 1-4, 2023. Media registration is available at www.astro.org/astro2023press, and general registration is available at www.astro.org/annualmeeting.
The American College of Surgeons (ACS) Clinical Congress 2023 will take place October 22-25 in Boston and will feature several opportunities for media members to learn about the latest trends and research in surgery and healthcare.
Join us as we gather at the 2023 ASCM Annual Meeting, World Congress on Exercise is Medicine and World Congress on the Basic Science of Physical Activity and Aging Biology showcasing the latest in exercise science and sports medicine. These three exciting meetings will happen simultaneously and will feature 200+ hours of ground-breaking trends and research in sports medicine and exercise science. The 2023 ACSM Annual Meeting will be held May 30 to June 2 at the Hyatt Regency and Colorado Convention Center in beautiful Denver, CO.
The American Association of Critical-Care Nurses hosts its annual National Teaching Institute & Critical Care Exposition (NTI) May 22-24 in Philadelphia. NTI -- the world’s largest conference for nurses who care for acutely and critically ill patients -- includes the Critical Care Exposition, the largest and most comprehensive trade show specifically for progressive care and critical care nurses.
First-generation bioresorbable vascular scaffolds (BVS) may be just as effective as drug-eluting metallic stents, which are currently the standard treatment for heart disease patients undergoing percutaneous coronary intervention (PCI).
Researchers from the Gene Therapy Program (GTP) at the Perelman School of Medicine at the University of Pennsylvania will present nine abstracts highlighting their translational science and discovery research on gene therapy, gene editing, and adeno-associated virus (AAV) vector technology at the American Society of Cell and Gene Therapy (ASGCT) 26th Annual Meeting on May 16–20, 2023 in Los Angeles, California.
UCLA Health Nursing and School of Nursing will host its 19th Annual Nursing Science and Innovation Conference on May 31 at the UCLA Covel Commons.
We’re mere days away from the largest gathering of respiratory health professionals! You can still register to cover ATS 2023 in Washington, DC. Before you join us, here are some of the research abstracts that will be presented to this year’s gathering of pulmonary, critical care and sleep medicine health professionals.
The Cardiovascular Research Foundation (CRF) announced that TVT: The Structural Heart Summit will feature 15 Late-Breaking Clinical Science studies. An annual meeting featuring cutting-edge research and techniques for structural heart interventions, TVT will take place June 7-10, 2023, at the Phoenix Convention Center – West in Phoenix, Arizona.
Hackensack Meridian Hackensack University Medical Center’s Department of Urology presented 14 abstracts at the American Urological Association’s (AUA) 2023 Annual Meeting.
Anzela Niraula, Ph.D., of the University of Washington in Seattle, won the Endocrine Society's 2023 Endocrine Images Art Competition for her image of the microglia mandala. This contest celebrates the beauty of endocrine science, and entries were judged based on aesthetic value and significance to endocrine research.
With optoacoustic tomography emerging as an effective breast cancer screening method, Seonyeong Park of the University of Illinois Urbana-Champaign and her team wanted to determine its reliability in patients with darker skin. They simulated a range of skin colors and tumor locations using digital breasts to make rapid and cost-effective evaluations, and the results confirmed that tumors could be harder to locate in individuals with darker skin. Park has developed a virtual framework that allows for more comprehensive investigations and can serve as a tool for evaluating and optimizing new OAT imaging systems in their early stages of development.
Join us July 22-25 in Boston for an exciting lineup of scientific symposia, educational sessions, hot-topic discussions, and award lectures covering the latest developments in nutrition science.
A study at the Yale University School of Medicine looked at data from the National Cancer Database for this six-year period and compared the 5-year survival rates for patients who had surgical resection and patients who elected to have SBRT. Overall, 30,658 patients were identified, including 24,729 (80.7%) who underwent surgery and 5,929 (19.3%) treated with SBRT.
Each year, 3 out of 10,000 babies will be born with critical left heart obstruction (CLHO). Most infants born with severe left-sided cardiac defects, such as CLHO, require at least three major open-heart surgeries before the age of 5.
At the 184th ASA Meeting, Ashley Alva of the Georgia Institute of Technology will describe how attaching microbubbles to macrophages, a type of white blood cell, can create high-resolution and sensitive tracking images useful for disease diagnosis. Because of the attached microbubbles, the cells sent back an echo when hit with ultrasound, which is nonionizing and noninvasive and has great depth of penetration. This allowed the team to visualize the macrophages in vivo with high resolution and sensitivity. Visualizing macrophages in vivo could also provide a powerful tool for understanding immune responses and monitoring therapeutic efficacy.
Imagine a cocktail party full of 3D-printed, humanoid robots listening and talking to each other. That seemingly sci-fi scene is the goal of the Augmented Listening Laboratory at the University of Illinois Urbana-Champaign. With precise control over the simulated subjects, the researchers can adjust the parameters of the experiment and even set the machines in motion to simulate neck movements. They will describe the talking human head simulators, and their work investigating how humans receive sound and developing audio technology, at the 184th ASA Meeting.
At the 184th ASA Meeting, Emily Sandgren and Joshua Alexander of Purdue University will describe experiments to determine the best hearing aids for listening to music. To test and compare, they took over 200 recordings of music samples as processed by hearing aids from seven popular manufacturers. They asked study participants to rate the sound quality of these recordings and found that the hearing aids had lower ratings for music than their control stimuli. The researchers found bigger differences in music quality between hearing aid brands than between speech and music programs.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
